MetLife Investment Management’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $283K | Hold |
|
|||||
|
2025
Q1 | $248K | Sell |
|
|||||
|
2024
Q4 | $266K | Buy |
|
|||||
|
2024
Q3 | $219K | Hold |
|
|||||
|
2024
Q2 | $191K | Buy |
|
|||||
|
2024
Q1 | $171K | Hold |
|
|||||
|
2023
Q4 | $184K | Hold |
|
|||||
|
2023
Q3 | $172K | Hold |
|
|||||
|
2023
Q2 | $186K | Hold |
|
|||||
|
2023
Q1 | $153K | Hold |
|
|||||
|
2022
Q4 | $110K | Hold |
|
|||||
|
2022
Q3 | $117K | Hold |
|
|||||
|
2022
Q2 | $132K | Hold |
|
|||||
|
2022
Q1 | $174K | Buy |
|
|||||
|
2021
Q4 | $115K | Buy |
|